Related Experiment Videos
Update on anticoagulant medications for the interventional radiologist
Rakesh P Mehta1, Matthew S Johnson
1Section of Hematology and Oncology, Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana 46202, USA.
New anticoagulant medications offer targeted thrombosis treatment, evolving clinical guidelines. Understanding these agents is crucial for interventional radiologists managing patients on anticoagulation.
Area of Science:
- Pharmacology
- Interventional Radiology
- Thrombosis Management
Background:
- Historically, anticoagulant options were limited to vitamin K antagonists, unfractionated heparin, and aspirin.
- Recent decades have seen the development of novel anticoagulant agents for thrombosis treatment.
- This expansion necessitates updated treatment algorithms for venous and arterial thrombotic events.
Purpose of the Study:
- To review traditional and novel anticoagulant medications.
- To discuss the role of these agents in interventional radiology.
- To highlight the importance of understanding anticoagulant mechanisms, risks, and benefits.
Main Methods:
- Literature review of anticoagulant medications.
- Analysis of current treatment guidelines.
- Discussion of clinical implications for interventional radiology procedures.
Main Results:
- A growing number of anticoagulant medications are available, leading to evolving treatment guidelines.
- Interventional radiologists frequently encounter patients on prophylactic or therapeutic anticoagulation.
- Understanding the nuances of various anticoagulants is increasingly vital for patient care.
Conclusions:
- The evolving landscape of anticoagulation requires continuous education for healthcare providers.
- Interventional radiologists must be adept at managing patients with diverse anticoagulant regimens.
- A comprehensive understanding of anticoagulant pharmacology is essential for safe and effective practice.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Venous Thrombosis IV: Nursing Management
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Imaging Studies VII: Vascular Imaging